ME
PBH icon

McIlrath & Eck’s Prestige Consumer Healthcare PBH Stock Holding History

McIlrath & Eck’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-166
Closed -$10.4K – 1007
2025
Q3 		$10.4K Sell
166
-793
-83% -$55.2K ﹤0.01% 619
2025
Q2 		$76.6K Hold
959
– – 0.01% 244
2025
Q1 		$82.4K Hold
959
– – 0.01% 227
2024
Q4 		$74.9K Buy
959
+154
+19% +$12K 0.01% 232
2024
Q3 		$58K Sell
805
-111
-12% -$7.86K 0.01% 278
2024
Q2 		$63.1K Buy
916
+556
+154% +$37.7K 0.01% 242
2024
Q1 		$26.1K Buy
360
+203
+129% +$13.6K ﹤0.01% 398
2023
Q4 		$9.61K Buy
157
+57
+57% +$3.38K ﹤0.01% 568
2023
Q3 		$5.72K Hold
100
– – ﹤0.01% 629
2023
Q2 		$5.94K Hold
100
– – ﹤0.01% 637
2023
Q1 		$6.26K Buy
+100
New +$6.24K ﹤0.01% 624

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

McIlrath & Eck's PBH Position: Q4 2025 in Review

McIlrath & Eck sold out of Prestige Consumer Healthcare (PBH) in Q4 2025, closing a stake of 166 shares — an estimated $10.4K sold.

McIlrath & Eck first reported a position in PBH in Q1 2023 and held it in 11 quarters. The position peaked at $82.4K in Q1 2025. 354 funds tracked by Wall St. Rank hold PBH as of Q4 2025.

  • McIlrath & Eck reported no remaining Prestige Consumer Healthcare position as of Q4 2025 after selling out during the quarter.
  • McIlrath & Eck sold 166 Prestige Consumer Healthcare shares in Q4 2025, an estimated $10.4K.
  • McIlrath & Eck first reported a position in Prestige Consumer Healthcare in Q1 2023 and held it in 11 quarters.
  • McIlrath & Eck's Prestige Consumer Healthcare position peaked at $82.4K in Q1 2025.
  • 354 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2025.

Based on McIlrath & Eck's 13F filing for Q4 2025, filed 3 Feb 2026.